GE HealthCare Technologies Inc. (GEHC)
(Delayed Data from NSDQ)
$91.34 USD
+0.52 (0.57%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $91.35 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Company Summary
Chicago, IL-based GE HealthCare Technologies Inc. or GE HealthCare is one of the leading providers of medical technology, pharmaceutical diagnostics, and digital solutions with focus on precision care. The company was formed on Jan 3, 2023, following a spin-off by its parent company — the General Electric Company.
The company’s products and services include medical devices, single-use and consumable products, service capabilities and digital solutions. It uses integrated diagnostics, artificial intelligence (AI) and machine learning for providing clinical decision support, highly personalized therapies enabled by more precise diagnostics, and remote patient ...
Company Summary
Chicago, IL-based GE HealthCare Technologies Inc. or GE HealthCare is one of the leading providers of medical technology, pharmaceutical diagnostics, and digital solutions with focus on precision care. The company was formed on Jan 3, 2023, following a spin-off by its parent company — the General Electric Company.
The company’s products and services include medical devices, single-use and consumable products, service capabilities and digital solutions. It uses integrated diagnostics, artificial intelligence (AI) and machine learning for providing clinical decision support, highly personalized therapies enabled by more precise diagnostics, and remote patient monitoring. It has a large global installed base of medical imaging, ultrasound and patient monitoring systems. GE HealthCare has extensive reach throughout the global healthcare system for medical technology, pharmaceutical diagnostics, and digital solutions with presence in more than 160 countries and a network of 43 manufacturing sites across 17 countries.
GE HealthCare reports under four business segments — Imaging, Ultrasound, Patient Care Solutions (PCS) and Pharmaceutical Diagnostics (PDx). The company’s Imaging portfolio comprises six product lines and associated service capabilities — Molecular Imaging (MI), Computed Tomography (CT), Magnetic Resonance (MR), Image-Guided Therapies, Women’s Health (WH) and X-ray. Ultrasound portfolio caters to Radiology and Primary Care, Women’s Health, Cardiovascular, Point of Care and Handheld, and Surgical Visualization & Guidance. PCS portfolio comprises five product lines — Patient Monitoring, Anesthesia Delivery and Respiratory Care, Diagnostic Cardiology, Maternal Infant Care, and Consumables and Services. The PDx business comprises two business lines — Contrast Media and Molecular Imaging.
FY23 at Glance
In 2023, GE HealthCare reported revenues of $19.6 billion, up 7% over FY22. Adjusted EPS for the year declined 15.1% year over year to $3.93.
General Information
GE HealthCare Technologies Inc
500 WEST MONROE STREET
CHICAGO, IL 60661
Phone: 833-735-1139
Fax: NA
Web: http://www.gehealthcare.com
Email: investor@gehealthcare.com
Industry | Medical Info Systems |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 9/30/2024 |
Earnings Date | 10/30/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 1.06 |
Current Year EPS Consensus Estimate | 4.26 |
Estimated Long-Term EPS Growth Rate | 6.30 |
Earnings Date | 10/30/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 90.82 |
52 Week High | 94.55 |
52 Week Low | 62.35 |
Beta | 1.18 |
20 Day Moving Average | 3,431,694.50 |
Target Price Consensus | 96.44 |
4 Week | 0.22 |
12 Week | 13.64 |
YTD | 17.46 |
4 Week | -1.97 |
12 Week | 5.04 |
YTD | -4.09 |
Shares Outstanding (millions) | 456.66 |
Market Capitalization (millions) | 41,474.06 |
Short Ratio | NA |
Last Split Date | NA |
Dividend Yield | 0.13% |
Annual Dividend | $0.12 |
Payout Ratio | 0.03 |
Change in Payout Ratio | NA |
Last Dividend Payout / Amount | 7/19/2024 / $0.03 |
Fundamental Ratios
P/E (F1) | 21.32 |
Trailing 12 Months | 22.31 |
PEG Ratio | 3.40 |
vs. Previous Year | 8.70% |
vs. Previous Quarter | 11.11% |
vs. Previous Year | 0.46% |
vs. Previous Quarter | 4.06% |
Price/Book | 5.31 |
Price/Cash Flow | 17.18 |
Price / Sales | 2.13 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 25.26 |
3/31/24 | 25.32 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 5.79 |
3/31/24 | 5.64 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 1.06 |
3/31/24 | 1.06 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 0.82 |
3/31/24 | 0.83 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 9.55 |
3/31/24 | 9.36 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 8.10 |
3/31/24 | 8.05 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 11.96 |
3/31/24 | 11.93 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 17.12 |
3/31/24 | 16.26 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 5.69 |
3/31/24 | 5.55 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 1.05 |
3/31/24 | 1.11 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 51.83 |
3/31/24 | 53.16 |